Are side-effects of irradiation predictable for treatment of breast cancer patients?

Predictive Diagnostics and Personalized Treatment: Dream or Reality

Volumn , Issue , 2009, Pages 447-456

  Yeghiazaryan, Kristina ^a   Braun, Michael ^a   Mamlouk, Soulafa ^a   Schild, Hans H ^a   Golubnitschaja, Olga ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958121545     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (24)

1. Doll C, Durand R, Grulkey W, Sayer S, Olivotto I (1999) Functional assessment of cutaneous microvasculature after radiation. Radiother. Oncol., 51, 67-70.
2. Kurtz JM, Miralbell R (1992) Radiation therapy and breast conservation: cosmetic results and complications. Semin. Radiat. Oncol., 2, 125-131.
3. Hardenbergh PH, Bentel GC, Prosnitz LR, Marks LB (1999) Postmastectomy radiotherapy: toxicities and techniques to reduce them. Semin. Radiat. Oncol., 9, 259-268.
4. Cowen D, Gonzague-Casabianca L, Brenot-Rossi I, Viens P, Mace L, Hannoun-Levi JM, Alzieu C, Resbeut M (1998) Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 41, 809-815.
5. Curtis RE, Boice JD Jr, Moloney WC, Ries LG, Flannery JT (1990) Leukemia following chemotherapy for breast cancer. Cancer Res., 50, 2741-2746.
6. Mermershtain W, Cohen AD, Koretz M, Cohen Y (2002) Cutaneous angiosarcoma of breast after lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast carcinoma: case report and review of the literature. Am. J. Clin. Oncol., 25, 597-598.
7. Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer, 92, 172-180.
8. Ampil FL, Burton GV, Li BD (2001) "Routine" weekly blood counts during breast irradiation for early stage cancer: are they really necessary? Breast J., 7, 450-452.
9. Gyenes G, Fornander T, Carlens P, Rutqvist LE (1994) Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 28, 1235-1241.
10. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE (1997) Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur. J. Nucl. Med., 24, 286-292.
11. Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P, for the Ontario Clinical Oncology Group (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: Results of a Randomized Trial. Cancer, 88, 2260-2266.
12. Levy S, Herberman R, Lippman M, d'Angelo T (1987) Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J. Clin. Oncol., 5, 348-353.
13. Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother. Oncol., 69, 145-153.
14. Navarro J, Obrador E, Pellicer JA, Aseni M, Viña J, Estrela JM (1997) Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic. Biol. Med., 22, 1203-1209.
15. La Torre F, Orlando A, Silipigni A, Giacobello T, Pergolizzi S, Aragona M (1997) [Increase of oxygen free radicals and their derivatives in chemo- and radiation treated neoplasm patients]. Minerva Med., 88, 121-126.
16. Yeghiazaryan K, Mamlouk S, Trog D, Moenkemann H, Braun M, Kuhn W, Schild H, Golubnitschaja O (2007) Irradiated breast cancer patients demonstrate subgroup-specific regularities in protein expression patterns of circulating leukocytes. Cancer Genomics Proteomics, 4, 411-418.
17. Hortobagyi GN (2005) Introduction and background. In: Molecular oncology of Breast Cancer (Ross JS and Hortobobagyi GN, eds). London, Jones and Bartlett Publ Int, 1-11.
18. Kültz D (2005) Molecular and evolutionary basis of the cellular stress response. Annu. Rev. Physiol., 67, 225-257.
19. Deroo BJ, Hewitt SC, Peddada SD, Korach KS (2004) Estradiol regulates the thioredoxin antioxidant system in the mouse uterus. Endocrinology, 145, 5485-5492.
20. Golubnitschaja O (2007) Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids, 32, 359-371.
21. Bradshaw TD, Matthews CS, Cookson J, Chew EH, Shah M, Bailey K, Monks A, Harris E, Westwell AD, Wells G, Laughton CA, Stevens MF (2005) Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res., 65, 3911-3919.
22. Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S (2002) Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin. Biochem., 35, 275-279.
23. Alexeyev MF, Ledoux SP, Wilson GL (2004) Mitochondrial DNA and aging. Clin. Sci. (Lond), 107, 355-364.
24. Hodge DR, Peng B, Pompeia C, Thomas S, Cho E, Clausen PA, Marquez VE, Farrar WL (2005) Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol. Ther., 4, 585-592.